We conclude that the up-regulation of miR-181a or down-regulation of CRY1 is directly associated with the inhibition of the TLR/NF-κB pathway, which reduces both the GS and RTE injury in CKD. This evidence concerns the gene CRY1 and chronic kidney disease.